Cargando…
Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway
BACKGROUND: Hypoxia is an important cause of myocardial injury due to the heart’s high susceptibility to hypoxia. Astragaloside IV (AS-IV) is the main component of Astragalus membranaceus and could exert cardiac protective role. Here, the effect of AS-IV on hypoxia-injured H9c2 cardiomyocytes was el...
Autores principales: | Li, Bei, Yu, Junjian, Liu, Peipei, Zeng, Taohui, Zeng, Xueliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506767/ https://www.ncbi.nlm.nih.gov/pubmed/34733987 http://dx.doi.org/10.21037/atm-21-4080 |
Ejemplares similares
-
Asiaticoside alleviates cardiomyocyte apoptosis and oxidative stress in myocardial ischemia/reperfusion injury via activating the PI3K-AKT-GSK3β pathway in vivo and in vitro
por: Zeng, Xueliang, et al.
Publicado: (2022) -
3'-daidzein sulfonate protects myocardial cells from hypoxic-ischemic injury via the NRF2/HO-1 signaling pathway
por: Zeng, Xueliang, et al.
Publicado: (2021) -
Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
por: Wu, Yang, et al.
Publicado: (2020) -
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
por: Sui, Yan-Bo, et al.
Publicado: (2019) -
HIF-3α affects preeclampsia development by regulating EVT growth via activation of the Flt-1/JAK/STAT signaling pathway in hypoxia
por: Qu, Hongmei, et al.
Publicado: (2021)